Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

11 trials with published results (21%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.7%

3 terminated out of 53 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

37%

11 of 30 completed with results

Key Signals

11 with results91% success

Data Visualizations

Phase Distribution

44Total
Not Applicable (35)
Early P 1 (1)
P 1 (2)
P 2 (5)
P 4 (1)

Trial Status

Completed30
Recruiting14
Active Not Recruiting3
Terminated3
Enrolling By Invitation2
Withdrawn1

Trial Success Rate

90.9%

Benchmark: 86.5%

Based on 30 completed trials

Clinical Trials (53)

Showing 20 of 20 trials
NCT05742698Phase 2Terminated

Nabilone for Agitation in Frontotemporal Dementia

NCT07650188Not ApplicableRecruitingPrimary

Stimulating the Aging Brain Using Brain and Sensory Stimulation

NCT06511752Early Phase 1Recruiting

Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia

NCT05741853Not ApplicableRecruitingPrimary

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia

NCT06191198Phase 2RecruitingPrimary

Communication Bridge 3 Study

NCT05368350Not ApplicableActive Not RecruitingPrimary

Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation

NCT05386394Phase 2RecruitingPrimary

Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia

NCT03313011Recruiting

The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

NCT00537004RecruitingPrimary

Language in Primary Progressive Aphasia

NCT05978804Not ApplicableTerminated

Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease

NCT04290988Not ApplicableTerminated

Circuitry Assessment and Reinforcement Training Effects on Recovery

NCT02736695Phase 1CompletedPrimary

Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia

NCT06529744Recruiting

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

NCT04566731Not ApplicableCompletedPrimary

Treating Primary Progressive Aphasia (PPA) Using tDCS

NCT04881617Not ApplicableActive Not RecruitingPrimary

Treatment for Speech and Language in Primary Progressive Aphasia

NCT01818661Phase 4Recruiting

Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech

NCT04046991Phase 2CompletedPrimary

Treating Primary Progressive Aphasia (PPA) Using High-definition tDCS

NCT05901233Not ApplicableEnrolling By InvitationPrimary

Speech-Language Treatment With Remotely Supervised Transcranial Direct Current Stimulation in Primary Progressive Aphasia

NCT06649084Not ApplicableEnrolling By InvitationPrimary

Primary Progressive Aphasia Multicomponent Language Treatment Study

NCT03887481Not ApplicableRecruiting

Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA

Scroll to load more

Research Network

Activity Timeline